Engineers have discovered how to make glass an information storage powerhouse.
Read more
Replacing potatoes or rice with pulses can lower your blood glucose levels by more than 20 per cent, according to a first-ever University of Guelph study.
Prof. Alison Duncan, Department of Human Health and Nutritional Sciences, and Dan Ramdath of Agriculture and Agri-Food Canada, found that swapping out half of a portion of these starchy side dishes for lentils can significantly improve your body’s response to the carbohydrates.
Replacing half a serving of rice with lentils caused blood glucose to drop by up to 20 per cent. Replacing potatoes with lentils led to a 35-per-cent drop.
Read more
Solar & Wind Energy Tower
Posted in energy
DigiLens, a developer of transparent waveguide display technology, says it’s working toward a waveguide display which could bring a 150 degree field of view to AR and VR (or XR) headsets. The company expects the display will be available in 2019.
Founded in 2005, DigiLens has developed a proprietary waveguide manufacturing process which allows the company to “print” light manipulating structures (Bragg gratings) into a thin and transparent material wherein light can be guided along the optic and be made to project perpendicularly, forming an image in the user’s eye. While DigiLens isn’t the only company which makes waveguide displays, they claim that their process offers a steep cost advantage compared to competitors. The company says they’ve raised $35 million between its Series A and B investment rounds.
While DigiLens’ displays have primarily been used in HUD-like applications, the company is increasingly positioning its wares toward the growing wearable, AR, and VR industries. At AWE 2018 last week, DigiLens Founder & CTO Jonathan Waldern told me that the company expects to offer a waveguide display suitable for AR and VR headsets which could offer a 150 degree field of view between both eyes. He said that a single display could be suitable for AR and VR modes in the same headset by utilizing a liquid crystal blackout layer which can switch between transparent and opaque, something which DigiLens partner Panasonic has developed. A clip-on light blocker or other type of tinting film ought to be suitable as well.
Read more
Too bad the middle class is shrinking!
The rate of growth in residential rooftop solar photovoltaics (PV) in Australia since 2008 has been nothing short of breathtaking.
Our new research suggests that the households most likely to join in the solar spree are those that are affluent enough to afford the upfront investment, but not so wealthy that they don’t worry about their future power bills.
Australia now has the highest penetration of residential rooftop PV of any country in the world, with the technology having been installed on one in five freestanding or semi-detached homes. In the market-leading states of Queensland and South Australia this ratio is about one in three, and Western Australia is not far behind, with one in four having PV.
Getting sick in a healthy way
Posted in life extension
The idea of “healthy ageing” is a contradiction in terms.
Suppose you read the following sentence in an article about company management: “This factor is central in achieving successful bankruptcy.” It sounds rather weird, doesn’t it? What if you read this about football team training? “Contrary to popular belief, it is possible to lose a game in a successful way.” These are so-called oxymorons—by Oxford’s definition, “figures of speech in which apparently contradictory terms appear in conjunction.”
The contradictory nature of the statements above is more than just apparent—bankruptcy is the exact opposite of “success” for a company, and the same goes for losing a game for a football team. One can get very creative with these: “a blockbuster fiasco”; “the façade of the building deteriorated nicely”; and so on. Examples closer to home would be “healthy aging” or “aging gracefully”.
Sometimes, semantics do matter
Really excited to announce our new initiative to make early-stage rejuvenation therapies more accessible.
Our mission is to enable people to vastly extend their healthy lifespan and be part of the first generation to cure aging.
We support the development of rejuvenation therapies that undo the damage of aging by funding basic research, bringing together the world’s leading scientists at our annual Undoing Aging conference and helping startups that work on actual therapies for human use.
In addition, we are developing our ‘Personal Longevity Strategy’ which harnesses the enormous wealth of the world’s cutting-edge medical knowledge to empower people to make informed decisions about extending their healthy lifespan right now.
Good news: The toolkit for neurorehabilitation is growing.
___ MindMaze Consolidates First-ever FDA Approval for Inpatient and Outpatient Neurorehabilitation Therapy (press release): MindMaze, a leader in braintech, has today announced that it has obtained FDA clearance to launch its portable neurorehabilitation product, MindMotion™ GO, in the United States. Together with.
Read more
Onstage at the launch of Amazon’s Alexa Prize, a multimillion-dollar competition to build AI that can chat like a human, the winners of last year’s challenge delivered a friendly warning to 2018’s hopefuls: your bot will mess up, it will say something offensive, and it will be taken offline. Elizabeth Clark, a member of last year’s champion Sounding Board team from the University of Washington, was onstage with her fellow researchers to share what they’d learned from their experience. What stuck out, she said, were the bloopers.
Read more
We were interested to learn that Juvenescence Limited, a biotech and development company involved in the development of therapies that target the aging processes, has successfully raised $50 million in a series A financing round.
Jim Mellon, the chairman of Juvenescence Limited, said, “We are delighted with the progress we have made and the faith that investors have placed in us to build a world-class company, one that we hope will lead the field in longevity science for the benefit of humanity as well as yield superb returns for our shareholders. Our company ethos is to advance the science that will add years of healthy life to every human being, and that is exactly what we are executing on at record speed.”
Juvenescence has raised $63 million from various international investors since its creation in October 2016 and is now moving forward with a number of key projects. The company is comprised of a number of industry leaders in business as well as a solid scientific team led by Dr. Declan Doogan and Dr. Annalisa Jenkins.
Read more